What lessons can we learn from 20 years in the free-speech battleground? The first lesson is that we're losing ground on it, as Andrew Malcolm and I discuss. What started off as a free market has rapidly turned into an exercise in government/Big Tech control and intimidation.  We also discuss the GOP debate, the five-alarm fire that wasn't on Capitol Hill, the GOP's circular firing squad, and more!

"What is truth?" The same question that blinded Pilate has done the same to modern culture. In his new book, "The War on Men," Dr. Owen Strachan diagnoses the destruction wrought by the nihilistic sexual revolution and trans ideology, especially on men. We discuss the theological and practical issues surrounding traditional male roles and biology and why women should read this book with a careful eye for the truth.

An attempt to reach out to Russian youth may end up alienating Catholics in central and eastern Europe from Pope Francis. Veteran Vaticanista Francis X. Rocca of The Wall Street Journal joins me to discuss his report on pushback coming to the Vatican from those Catholics who remember Soviet domination much better than the pontiff apparently does. We discuss Pope Francis' blind spot when it comes to the Cold War, whether he's making a purposeful effort to set himself up as an honest broker in the Russo-Ukrainian War, and end up talking a bit about the upcoming synod.

Robert Menendez remains defiant, but is anyone listening? Andrew Malcolm and I discuss Menendez's stunning defense and its utter lack of credibility. We also marvel at the Washington Post's repudiation of its own poll and why they're doing so. How much longer can the Protection Racket Media circle the wagons around Joe Biden?

Why does Medicare pay two different rates for the same procedures? Dr. Richard Kube of Prairie Spine & Pain Institute of Peoria, Illinois explains how government sets incentives that eliminate patient choice and forces independent providers to pack up. Thirteen years after ObamaCare, the problems are only getting worse -- but some common sense changes could at least start us on the path of real reform.

What has gotten into our governing elite these days? Andrew and I discuss sex scandals involving three politicians and what it says about our low expectations these days. We also wonder how Bob Dole and Daniel Inouye could get into a suit for decades, and then wonder why John Fetterman needs and exception. Did Mitt Romney have a point in his retirement?

Does Michelle Luhan Grisham have the authority to suspend the Constitution? Andrew Malcolm and I debate next steps in New Mexico, as well as Joe Biden's absence from 9/11 anniversary commemorations. Is the White House afraid to put him out in public, or do they just not care about the anniversary of the deaths of 3,000 Americans? Plus, Andrew delivers a verdict on fruitcake, and discusses the rush to conclusions in the media about the GOP primary.

Two years after the Taliban takeover, ISIS is now also resurgent -- and insurgent in Afghanistan. Andrew Malcolm and I discuss the failures of American policy and execution that led to these outcomes and the silence of the media. We also discuss a new essay at the Free Press that exposes the Academia-Media corruption around climate change. Plus, Andrew discusses his beautiful essay at Red State about his father and the quiet connection that keeps unexpectedly returning.

Should we focus on who won or lost the debate? Or should we focus on what strategies the candidates used, and what those reveal? Andrew argues that both DeSantis and the GOP primary electorate need to take the "long road" approach, and more or less agree about Ramaswamy. I also regale Andrew with the harrowing tales of my jury duty this week, and more!

The Biden administration has announced its first ten prescription medicines to qualify for their price "negotiation" with manufacturers. This isn't much of a negotiation, as American Commitment president Phil Kerpen reveals. The new authority for price "negotiation" includes draconian tax penalties for those companies that refuse to allow Medicare/Medicaid to set price caps. The end result won't be cheaper medicines, Phil explains, but scarcity.